ArticleIUBMB life2025

A New Treatment Strategy for Lung Cancer With HDAC and Wnt/β-Catenin Pathway Inhibitors.

Elif Erturk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.